Robert Mittendorff, MD, MBA

The COVID19 Pandemic moved us a decade ahead in telemedicine. Primary and urgent care is being transformed with changes in consumer and patient expectations, improvements in telemedicine and monitoring technology, and consumer appetite for the consumption of these services. Medicare's recent favorable reimbursement has driven adoption with these drivers. Primary care, in particular, is being transformed. Care models are being reinvented and the practice of primary care is morphing from in -… Show more

The COVID19 Pandemic moved us a decade ahead in telemedicine. Primary and urgent care is being transformed with changes in consumer and patient expectations, improvements in telemedicine and monitoring technology, and consumer appetite for the consumption of these services. Medicare's recent favorable reimbursement has driven adoption with these drivers. Primary care, in particular, is being transformed. Care models are being reinvented and the practice of primary care is morphing from in - office episodic visits to multimodal in person, virtual, and continuous monitoring care. Show less

In this episode, Byron, Robert and Mudit talk about Qventus, healthcare, machine learning, AGI, consciousness, and medical AI.

Artificial Intelligence and Machine Learning are transforming the work of human labor. Healthcare professionals will see their work transformed and augmented with this technology, but the manner in which these changes will occur is nuanced. In this presentation, I will explore the manner in which the labor of healthcare will be transformed, review evidence to support this prediction, and remark on the changes already underway.

A podcast interview by Tom Salemi from Healthegy on the 2017 Digital Health space prior to the Digital Healthcare Innovation Summit

Digital health and the convergence of mobile technologies, sensors, persuasive design of software and analytics has afforded providers the opportunity to leverage the "labor" of healthcare to achieve equal or better clinical outcomes than traditional care has afforded them. These technology have the potential to truly increase both the scope of practice and the throughput of providers that employ them, with equal or improved safety and efficacy. This presentation will first tour the types of… Show more

Digital health and the convergence of mobile technologies, sensors, persuasive design of software and analytics has afforded providers the opportunity to leverage the "labor" of healthcare to achieve equal or better clinical outcomes than traditional care has afforded them. These technology have the potential to truly increase both the scope of practice and the throughput of providers that employ them, with equal or improved safety and efficacy. This presentation will first tour the types of digital health patient engagement models and metrics for both clinical and economic success. Following a detailed description of engagement and interventional models, we will review important studies in the digital health literature, both to understand the current advantages of the technology as well as its limitations. Show less

In this video, Ryan Floyd (Founding Managing Director of Storm Ventures), Arif Janmohamed (Partner at Lightspeed Venture Partners), Dr. Robert Mittendorff (Partner at Norwest Venture Partners), and Matt Bornstein (Principal at Blumberg Capital) address AI from the VC perspective. Gigaom’s Head of Research, Tim Crawford, moderates.

Healthcare delivery is becoming an increasingly complex operation. Nurses, physicians and other allied healthcare professionals are increasingly measured on their quality of work, even with increasing patient volume and patient complexity. Technology, from sensors to analytics to software based decision support and automation, have the potential to both leverage our healthcare provider workforce to mange increasing demands and to improve quality. This presentation will focus on the key areas of… Show more

Healthcare delivery is becoming an increasingly complex operation. Nurses, physicians and other allied healthcare professionals are increasingly measured on their quality of work, even with increasing patient volume and patient complexity. Technology, from sensors to analytics to software based decision support and automation, have the potential to both leverage our healthcare provider workforce to mange increasing demands and to improve quality. This presentation will focus on the key areas of opportunity for technology to improve the capabilities of healthcare providers in delivering quality care. Show less

Interview with Emily Chang: Series A on Bloomberg TV

Major shifts in payments, outcomes reporting, and technology are allowing novel business models to exist in healthcare delivery. We will take a look at the manner in which digital health companies can commercialize offerings with an eye towards the evolving payor and clinical evidence landscape.

Robert Mittendorff, MD, HX360 keynote speaker at HIMSS15, talks key themes of healthcare in 2015, including care coordination, digital therapeutics and telemedicine.

Pediatric head trauma is a common presenting complaint to the emergency department (ED) and is a major cause of pediatric death and disability. This article will address the epidemiology, pathophysiology, diagnosis, and management of moderate to severe pediatric traumatic brain injury (TBI), with a focus on strategies to improve outcome.

The biopharmaceutical industry is a dynamic one with many significant risks and uncertainties associated with product development, commercialization, and financing. Among these risks is the ability of biopharmaceutical companies to manufacture sufficient quantities of their products to meet the market demand. In recent years there has been significant concern over a potential “capacity crunch” in biomanufacturing capacity, especially for monoclonal antibodies, leading to a number of analyses on… Show more

The biopharmaceutical industry is a dynamic one with many significant risks and uncertainties associated with product development, commercialization, and financing. Among these risks is the ability of biopharmaceutical companies to manufacture sufficient quantities of their products to meet the market demand. In recent years there has been significant concern over a potential “capacity crunch” in biomanufacturing capacity, especially for monoclonal antibodies, leading to a number of analyses on this topic. Show less

Artificial Intelligence and Machine Learning are transforming the work of human labor. Healthcare professionals will see their work transformed and augmented with this technology, but the manner in which these changes will occur is nuanced. In this presentation, I will explore the manner in which the labor of healthcare will be transformed, review evidence to support this prediction, and remark on the changes already underway.